AstraZeneca prices USD2 billion multi-year bond issuance
(Alliance News) - AstraZeneca PLC on Thursday priced a global bond offering worth USD2 billion. Read More
| Price | 15,542.00p on 27-02-2026 at 18:19:33 |
|---|---|
| Change | 432.00p 2.86% |
| Buy | 15,504.00p |
| Sell | 15,498.00p |
| Last Trade: | Unknown 0.00 at 15,510.01329p |
| Day's Volume: | 2,574,721 |
| Last Close: | 15,542.00p |
| Open: | 15,196.00p |
| ISIN: | GB0009895292 |
| Day's Range | 15,172.00p - 15,542.00p |
| 52wk Range: | 9,574.00p - 15,730.00p |
| Market Capitalisation: | £241.02b |
| VWAP: | 15,485.12688p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 0 | 15,510.01329p | SI Trade Currency Conversion |
18:16:55 - 27-Feb-26 |
| Unknown* | 0 | 15,524.83201p | SI Trade Currency Conversion |
18:15:22 - 27-Feb-26 |
| Unknown* | 25 | 15,516.19269p | Cross Currency Conversion OTC Trade |
18:05:54 - 27-Feb-26 |
| Unknown* | 0 | 15,498.15831p | SI Trade Currency Conversion |
18:00:25 - 27-Feb-26 |
| Unknown* | 0 | 15,515.19984p | SI Trade Currency Conversion |
17:50:53 - 27-Feb-26 |
| Unknown* | 0 | 15,429.44345p | SI Trade Currency Conversion |
17:38:25 - 27-Feb-26 |
| Unknown* | 15 | 15,526.68435p | Currency Conversion OTC Trade |
17:35:04 - 27-Feb-26 |
| Unknown* | 0 | 15,512.2361p | SI Trade Currency Conversion |
17:33:14 - 27-Feb-26 |
| Unknown* | 0 | 15,496.67644p | SI Trade Currency Conversion |
17:24:00 - 27-Feb-26 |
| Unknown* | 0 | 15,411.94479p | SI Trade Currency Conversion |
17:19:48 - 27-Feb-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Feb 2026 7:00 am | RNS | AstraZeneca prices a $2bn bond offering |
| 25th Feb 2026 7:00 am | RNS | Filing of Form 20-F with SEC |
| 24th Feb 2026 11:00 am | RNS | Annual Financial Report |
| 24th Feb 2026 7:00 am | RNS | Directorate change |
| 20th Feb 2026 7:00 am | RNS | Fixed-duration Calquence combo approved in US |
| 10th Feb 2026 7:00 am | RNS | Final Results |
| 3rd Feb 2026 7:00 am | RNS | Update on Saphnelo subcutaneous administration |
| 2nd Feb 2026 3:00 pm | RNS | Total Voting Rights |
| 2nd Feb 2026 7:05 am | RNS | Imfinzi recommended in EU for early gastric cancer |
| 2nd Feb 2026 7:00 am | RNS | AstraZeneca begins trading on NYSE |